Cytodyn Inc (CYDY)

[misiu143]

MRI Reveals Significant Brain Abnormalities Post-COVID...

Yes , if only leronlimab will be approved ( or received EUA ) instead of remdesivir , tocilizumab , baricitinib , after the CD10 and CD12 ,
most probably these things will happened very rarely , as from what we know from all the research now , they most probably are due to severe neuro-inflammation ,
and we know for a VERY long time leronlimab crosses BBB , and it is a very strong anti-inflammatory molecule , without one serious side effect , in contrary to above mention drugs..they are with a very poor efficacy , and severe side effects..

Hmmm, I wonder why they were approved , and leronlimab was not ....hmmmmm

ALL imo.

https://neurosciencenews.com/post-covid-brain-21904/

GLTA longs..